gastroparesis and glp 1 drugs Lawsuits involving popular GLP-1 medications such as Ozempic, Wegovy, Mounjaro continue to grow as patients report serious side effects, including gastroparesis, severe gastrointestinal complications, and NAION vision loss. These medications, widely INCIDENCE OF GASTROINTESTINAL SIDE EFFECTS

Tirzepatide, used in Zepbound and Mounjaro, targets both the GLP-1 and the GIP receptor agonist, while semaglutide, found in Wegovy and Ozempic, mimics only the GLP-1 receptor agonist, a type of hormone in the body that impacts everything from the brain to muscle to the pancreas, stomach and liver

Eat enough quality protein

7/3/23 2 Yahoo Finance

Patients using GLP-1 medications had twice the risk of developing vision-threatening nAMD compared with those not taking these drugs

Special populations and considerations Different patient populations have different considerations when it comes to choosing between insulin and GLP-1 therapy